fbpx
Covid Info

New research study for Type 1 Diabetes patients where their current long-acting insulin will be replaced by a once-weekly study insulin or approved daily long-acting insulin.

About The Study

This study is for patients with Type 1 Diabetes who are not currently using an insulin pump. Patients will have their current long-acting insulin replaced by either a once-weekly study insulin or an approved daily long-acting insulin, Tresiba. The weekly long-acting study insulin can help reduce the number of shots patients have to take each day.

Study participants will receive study-related care and study medication/supplies at no charge. You may also receive compensation for travel expenses

To take part in the study, participants should be:

  • Adults with Type 1 Diabetes
  • A1C 7.0 and 10.0%
  • Not using an insulin pump

See if you qualify
Study Image

What Is a Study?

  • A clinical study helps advance the future of diabetes! Research patients try new meds or devices not yet available to the public, at no cost to them.
  • Research patients meet with a study coordinator and doctor multiple times to monitor them.
  • Each visit, patients are compensated for travel expenses.
  • Study patients must meet a list of criteria in order to be a part of a study.
  • A study can last anywhere from six months to a few years.

Join this study!

If you want to see if you qualify for a study, share your information and we will contact you. Want to speak with someone immediately? Call (515) 329-5690.

Please enter your first name.
Please enter your last name.
Please enter a valid phone number.
Please enter a valid email address.

Benefits


Receive free medications and free supplies!

Gain better understanding of your disease and take an active role in your health.

Obtain treatments not yet available and contribute to medical research.

Travel stipends for attending most scheduled research appointments.

On average patients receives free care worth $250 - $500 from diabetes experts.

So far Iowa Diabetes Research has spent more than $500K on patients benefits

Our Caring Team

Anuj Bhargava

Dr. Anuj Bhargava

CEO and Medical Director

Kathy Fitzgerald

Kathy Fitzgerald

Sub-Investigator

Christine Burke

Christine Burke

Sub-Investigator

Tara Herrold

Tara Herrold

CRC Manager

Lisa Borg

Lisa Borg

Clinical Research Coordinator

Natalie Young

Natalie Young

Clinical Research Coordinator

Kendra Kramer

Kendra Kramer

Clinical Research Coordinator

Kara Turner

Kara Turner

Clinical Research Coordinator

Allie Fowler

Allie Fowler

Clinical Research Coordinator

Have questions? Call us at (515) 329-6800 or email us at info@iowadiabetes.com.